National Institutes of Health: all 11,571 studies

Page 40 of 116. Open to participants first (946), then studies with results posted, then the rest; newest registration first within each.

• Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal CancerActive, not recruitingNCT03233711Phase 3
• Extracellular RNAs in Relation to Cardiometabolic RiskCompletedNCT03225196
• RNA Sequencing in the Framingham Heart Study Third Generation Cohort Exam 2CompletedNCT03225183
• Hearing Loss and the Effects of Statin Drugs in People With Head and Neck Squamous Cell Carcinoma Treated With Cisplatin ChemoradiationCompletedNCT03225157
• Dark Adaptation in Participants With Age-Related Macular DegenerationCompletedNCT03225131
• Impact of a Short-Term Analytical Treatment Interruption and Re-Initiation of Antiretroviral Therapy on Immunologic and Virologic Parameters in HIV-Infected IndividualsCompletedNCT03225118
• Measuring the Latency Connectome in the Central Nervous Systems Using Neuroimaging and Neurophysiological TechniquesCompletedNCT03223636
• Pathophysiology of Focal Hand DystoniaCompletedNCT03223623Not applicable
• Nivolumab or Expectant Observation Following Ipilimumab, Nivolumab, and Surgery in Treating Patients With High Risk Localized, Locoregionally Advanced, or Recurrent Mucosal MelanomaWithdrawnNCT03220009Phase 2
• Tazemetostat in Treating Patients With Metastatic or Unresectable Solid Tumors or B-Cell Lymphomas With Liver DysfunctionWithdrawnNCT03217253Phase 1
• NCI UNC Project ESCCTerminatedNCT03206125
• Loss of Depotentiation in Focal DystoniaTerminatedNCT03206112
• Brain Dopaminergic Signaling in Opioid Use DisordersCompletedNCT03190954Early Phase 1
• Effect of Isocaloric Ultra Processed Versus Unprocessed Diets on Insulin SensitivityCompletedNCT03189121
• Collection of Malignant Ascites, Pleural Fluid, and Blood From People With Solid TumorsTerminatedNCT03189108
• Breadth of Donor Options for People With Inherited Diseases Requiring Allogeneic Hematopoietic Stem Cell Transplant in the Era of Alternative Donor Transplants Using Post-Transplantation CyclophosphamideCompletedNCT03188419
• Gastric Cancer Precursor Lesions (GCPL) StudyCompletedNCT03188406
• 18F-DCFPyL PET/CT in High Risk and Recurrent Prostate CancerActive, not recruitingNCT03181867Phase 2
• Comparing One or Two Doses of the Human Papillomavirus Vaccine for the Prevention of Human Papillomavirus Infection, ESCUDDO StudyActive, not recruitingNCT03180034Phase 4
• Cervix Image Sharing Protocol (CISP)CompletedNCT03179306
• Empaglifozin in Early Diabetic Kidney DiseaseWithdrawnNCT03173963Phase 3
• 18F-DCFPyL PSMA- Versus 18F-NaF-PET Imaging for Detection of Metastatic Prostate CancerActive, not recruitingNCT03173924Phase 2
• Trial to Evaluate the Safety, Immunogenicity and Protective Efficacy of Three or Five Administrations of GAP3KO SporozoitesCompletedNCT03168854Phase 1
• Atopic Dermatitis (AD) and Food AllergyCompletedNCT03168113
• Examining the Knowledge, Attitudes, and Beliefs of Sickle Cell Disease Patients, Parents of Patients With Sickle Cell Disease, and Providers Towards the Integration of CRISPR in Clinical CareCompletedNCT03167450
• Exploring Gut-Brain and Brain-Gut Interactions in Alcohol Use Disorder Via Microbiota Investigations: A Pilot StudyCompletedNCT03152760
• Testing Atezolizumab Alone or Atezolizumab Plus Bevacizumab in People With Advanced Alveolar Soft Part SarcomaActive, not recruitingNCT03141684Phase 2
• Pharmacokinetic Evaluation of Nalmefene Administered Intranasally to Healthy VolunteersCompletedNCT03129347Phase 1
• Retrospective Study of Viral Reactivation Across All Bone Marrow Transplant Protocols Since 2010CompletedNCT03111745
• A Phase Ib Study of the Safety, Reactogenicity, and Immunogenicity of Sm-TSP-2/Alhydrogel)(R) With or Without AP 10-701 for Intestinal Schistosomiasis in Healthy Exposed AdultsCompletedNCT03110757Phase 1
• Mitogen Activated Protein Kinase Kinase (MEK1/2) Inhibitor Selumetinib (AZD6244 Hydrogen Sulfate) in People With Neurofibromatosis Type 1 (NF1) Mutated Gastrointestinal Stromal Tumors (GIST)WithdrawnNCT03109301Phase 2
• Testing the Ability of AMG 232 (KRT 232) to Get Into the Tumor in Patients With Brain CancerTerminatedNCT03107780Phase 1
• Upstate New York Infant Development Screening ProgramCompletedNCT03106493
• Pregnant Women s Views About the Ethics of Prenatal Whole Genome SequencingCompletedNCT03105492
• PREVAIL VI: Identification of Host Genetic Factors Underlying Ebola Virus Disease Risk, Mortality, Long-term Sequelae, Viral RNA Persistence, Humoral Immunity, and Ebola Vaccine ResponseCompletedNCT03098862
• Procedures for Sample Acquisition and Distribution for The Human Brain Collection CoreTerminatedNCT03092687
• Herpesviruses Reactivation In Hiv-Infected Women Initiating ART (HERA)CompletedNCT03092505
• AMD Ryan Initiative Study (ARIS)CompletedNCT03092492
• CD8 Reactivity to Microorganisms in Blood and Breast MilkTerminatedNCT03084614
• Discovery and Validation of Plasma DNA Methylation Biomarker for Detection of Stomach CancerCompletedNCT03076567
• A Pilot Study to Investigate the Safety and Clinical Activity of Avelumab (MSB0010718C) in Thymoma and Thymic Carcinoma After Progression on Platinum-Based ChemotherapyActive, not recruitingNCT03076554Phase 2
• Long-Term Stability of Oral Microbiome SamplesCompletedNCT03068546
• Pathophysiology of Acute Pain in Patients With Sickle Cell DiseaseCompletedNCT03049475
• The Physiological Responses and Adaptation of Brown Adipose Tissue to Chronic Treatment With Beta3-Adrenergic Receptor AgonistsCompletedNCT03049462Phase 1
• Neurophysiologic Study of Patient With Essential Tremor and Dystonic TremorCompletedNCT03041714
• Testing a New Chemotherapy Drug, KRT-232 (AMG-232) in Combination With Decitabine and Venetoclax in Patients With Acute Myeloid LeukemiaActive, not recruitingNCT03041688Phase 1
• Etiology of Eczema Herpeticum (EH)CompletedNCT03038932
• Hereditary Gastric Cancer Syndromes: An Integrated Genomic and Clinicopathologic Study of the Predisposition to Gastric CancerCompletedNCT03030404
• Novel Positron Emission Tomography (PET) Radiotracer to Image Phosphodiesterase-4B (PDE4B)TerminatedNCT03030391Phase 1
• Pembrolizumab and Recombinant Interleukin-12 in Treating Patients With Solid TumorsActive, not recruitingNCT03030378Phase 1
• Phase I Trial of Measles Vectored Chikungungya VaccineCompletedNCT03028441Phase 1
• The Developmental Origins of Suicide MortalityActive, not recruitingNCT03027440
• Prospective Evaluation and Molecular Profiling in People With Gastric TumorsCompletedNCT03027427
• Clinical Sequencing of Cancer and Tissue Repository: OncoGenomicsWithdrawnNCT03027401
• Clinical and Physiological Studies of Tremor SyndromesCompletedNCT03027310
• Beginning Assessment of Cutaneous Treatment Efficacy of Roseomonas in Atopic DermatitisCompletedNCT03018275Phase 1/2
• Neurophysiology of Surround Inhibition in the Human Motor CortexCompletedNCT03018262
• H5N8 Mix and Match With or Without AS03 or MF59 in Healthy Adults: ImmunologyCompletedNCT03014310Phase 1
• A Systems Biology Approach to Malaria ImmunityCompletedNCT03014258Phase 1
• Longitudinal Assessment of Transient Elastography in Cystic FibrosisCompletedNCT03001388
• Safety and Immune Response to a Clade C DNA HIV VaccineCompletedNCT02997969Phase 1
• Testing the Addition of Atezolizumab to Combination Chemotherapy or Atezolizumab Alone for Metastatic Colon or Rectal Cancer, the COMMIT StudyActive, not recruitingNCT02997228Phase 3
• Safety and Efficacy of Sanaria's PfSPZ-CVac in Malian AdultsCompletedNCT02996695Phase 1
• VRC 320: A Phase I, Randomized Clinical Trial to Evaluate the Safety and Immunogenicity of a Zika Virus DNA Vaccine, VRC-ZKADNA090-00-VP, Administered Via Needle and Syringe or Needle-free Injector, PharmaJet, inHealthy AdultsCompletedNCT02996461Phase 1
• Hyperthyroid Follow-Up StudyCompletedNCT02989103
• Lung Tissue Research ConsortiumCompletedNCT02988388
• MRI to Characterize and Predict CF Liver Disease in PUSH CohortCompletedNCT02979340
• Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin CancersActive, not recruitingNCT02978625Phase 2
• Impact of Malaria on Pregnant Women in Ouelessebougou, MaliCompletedNCT02974608
• Understanding How Cigarette Direct Mail Marketing Influences Smoking Behaviors Among High and Low Socioeconomic Status Young Adult SmokersWithdrawnNCT02974582Not applicable
• A Phase 1, First-in-human, Double-blinded, Randomized, Placebo-controlled Trial of a Zika Virus Purified Inactivated Vaccine (ZPIV) With Alum Adjuvant in Healthy Flavivirus-naive and Flavivirus-Primed Subjects.CompletedNCT02963909Phase 1
• Safety and Immunogenicity of Priming With Live Attenuated A/H7N9 Influenza Virus Vaccine Followed By Inactivated A/H7N9 Influenza Virus Vaccine With AS03 AdjuvantCompletedNCT02957656Phase 1
• Testing MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast CancerActive, not recruitingNCT02954874Phase 3
• ZIKA Vaccine in Naive SubjectsCompletedNCT02952833Phase 1
• Evaluating the Infectivity, Safety, and Immunogenicity of a Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine in RSV-Seronegative Infants and Children 6 to 24 Months of AgeCompletedNCT02952339Phase 1
• Safety and Effectiveness of a Seasonal Live Attenuated Influenza Vaccine in a Human Challenge Model of Infection With Wild-type (wt) Influenza A/California/2009 (H1N1)-Like VirusWithdrawnNCT02950688Phase 1
• Influence of Psychosocial Distress and Lifetime Trauma Exposure on Traumatic Stress Among Oncology Patients on Clinical TrialsCompletedNCT02948413
• Infectivity, Safety and Immunogenicity of a Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine (RSV LID cp ΔM2-2) in RSV-Seronegative Infants and Children 6 to 24 Months of AgeTerminatedNCT02948127Phase 1
• Natural History of Geographic Atrophy Associated With Age-Related Macular DegenerationCompletedNCT02941263
• Collection of Biological and Environmental Samples and Clinical Data From Anonymous Adult Men and Women for Quality Control and Methods Development and Evaluation (ASCA)WithdrawnNCT02940015
• Impact of GHRH on Sleep Promotion and Endocrine Regulation in Service Members Who Sustained a Traumatic Brain Injury and Have Current InsomniaWithdrawnNCT02931474Phase 2
• Talimogene Laherparepvec and Radiation Therapy in Treating Patients With Newly Diagnosed Soft Tissue Sarcoma That Can Be Removed by SurgeryActive, not recruitingNCT02923778Phase 2
• Cancer and Other Disease Risks in U.S. Nuclear Medicine TechnologistsCompletedNCT02911155
• Effects of Prism Adaption and rTMS on Brain Connectivity and Visual RepresentationCompletedNCT02911129
• Deep Brain Stimulation Surgery for Focal Hand DystoniaActive, not recruitingNCT02911103Phase 1/2
• Longitudinal Changes in the Oral and Gut Microbiome of Individuals With Alcohol DependenceCompletedNCT02911077
• Novel Mobile Device Application to Improve AdherenceCompletedNCT02904278Not applicable
• Focus Groups to Determine Surrogates Views Regarding Patient Preference PredictorsCompletedNCT02898194
• Post-Traumatic Stress Symptoms (PTSS) in Transplant RecipientsCompletedNCT02892266
• A Safety Trial to Test MVA-BN(R)-Filo and Ad26.ZEBOV Vaccines in Healthy VolunteersCompletedNCT02891980Phase 1
• Evaluating the Safety and Immunogenicity of a Live Attenuated Virus Vaccine to Prevent Influenza H3N2v DiseaseTerminatedNCT02883426Phase 1
• Evaluating the Safety and Immunogenicity of a Tetravalent Dengue Vaccine (TetraVax-DV) TV005 in Flavivirus-Naive Adults 50 to 70 Years of AgeCompletedNCT02879266Phase 1
• Linkage of Medicaid Enrollment Information to Surveillance, Epidemiology and End Results DataCompletedNCT02875327
• The Role of Emotions and Regulatory Focus in Decision Making That Involves Risk TradeoffsWithdrawnNCT02874053
• Evaluating the Safety and Protective Efficacy of a Single Dose of the Live Attenuated Tetravalent Dengue Vaccine TV005 to Protect Against Infection With rDEN3Δ30CompletedNCT02873260Phase 1
• Atezolizumab in Treating Patients With Cancer Following Adoptive Cell TransferActive, not recruitingNCT02862275Phase 1
• Disease Natural History and Biomarkers of SPG3A, SPG4A, and SPG31TerminatedNCT02859428
• CaREFREE Study (Calorie Restriction, Environment and Fitness: Reproductive Effects Evaluation Study)CompletedNCT02858336Not applicable
• Complement (C1q) Binding to HLA Antibodies in a Solid-phase Immunoassay and Clinical Effect on Platelet TransfusionCompletedNCT02858323
• Natural History of and Specimen Banking for People With Tumors of the Central Nervous SystemCompletedNCT02851706

← National Institutes of Health overview and focus areas